PHGDH acts on serine biosynthesis, and the inhibition of PHGDH was proposed to treat epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-resistant lung adenocarcinoma (28). The gene discussed is EGFR; the disease is lung adenocarcinoma.